HTR2A and Anxiety: That is, the exposure to 5-HT2A and 5-HT2C antagonists during the early postnatal period prevents the anxiety and depressive-like phenotypes induced by fluoxetine, while the treatment in the same period with agonists of the same receptors produces anxiety104.